Diopentolate en es it fr

Diopentolate Brand names, Diopentolate Analogs

Diopentolate Brand Names Mixture

  • No information avaliable

Diopentolate Chemical_Formula


Diopentolate RX_link

No information avaliable

Diopentolate fda sheet

Diopentolate msds (material safety sheet)

Diopentolate MSDS

Diopentolate Synthesis Reference

No information avaliable

Diopentolate Molecular Weight

291.385 g/mol

Diopentolate Melting Point

139 oC (hydrochloride salt)

Diopentolate H2O Solubility

No information avaliable

Diopentolate State


Diopentolate LogP


Diopentolate Dosage Forms

Ophthalmic solution (eye drops)

Diopentolate Indication

Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.

Diopentolate Pharmacology

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

Diopentolate Absorption

Absorbed following ophthalmic administration.

Diopentolate side effects and Toxicity

Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.

Diopentolate Patient Information

No information avaliable

Diopentolate Organisms Affected

Humans and other mammals